315 related articles for article (PubMed ID: 21090109)
1. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
[TBL] [Abstract][Full Text] [Related]
2. [Construction of the eukaryotic expression vector with IL-2 gene and VP2 gene of PPV and research on immunogenicity].
Cui BA; Wei ZY; Wang XB; Huang KH; Jin XX; Dong ZJ; Zheng LL
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):425-30. PubMed ID: 16755922
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of human parvovirus B19 virus-like particles].
Zou X; Dong L; Song J; Qu J; Yu X; Lu Z; Hong T
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):575-9. PubMed ID: 19637634
[TBL] [Abstract][Full Text] [Related]
4. [Immune Response of Recombinant Pseudorabies Virus rPRV-VP2 Expressing VP2 Gene of Porcine Parvovirus in Mice].
Fu P; Pan X; Han Q; Yang X; Zhu Q; Guo X; Zhang Y; Chen H
Bing Du Xue Bao; 2016 Mar; 32(2):195-202. PubMed ID: 27396164
[TBL] [Abstract][Full Text] [Related]
5. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine.
Chen Y; Guo W; Xu Z; Yan Q; Luo Y; Shi Q; Chen D; Zhu L; Wang X
Virol J; 2011 Jun; 8():307. PubMed ID: 21679423
[TBL] [Abstract][Full Text] [Related]
6. [Effect of the glycine-rich region deleted PPV VP2 to the VLPs].
Chen D; Guo W; Chen Y; Xu Z; Li W; Ren Y; Wang X
Sheng Wu Gong Cheng Xue Bao; 2011 Dec; 27(12):1729-41. PubMed ID: 22506413
[TBL] [Abstract][Full Text] [Related]
7. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein.
Chen Z; Li C; Zhu Y; Wang B; Meng C; Liu G
Virus Res; 2012 Oct; 169(1):306-9. PubMed ID: 22940567
[TBL] [Abstract][Full Text] [Related]
9. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6.
Zheng HH; Wang LQ; Fu PF; Zheng LL; Chen HY; Liu F
Virol J; 2020 Feb; 17(1):19. PubMed ID: 32014014
[TBL] [Abstract][Full Text] [Related]
11. [Co-expression of CSFV T cell epitope E290 peptide and PPV VP2 protein in Lactobacillus casei and determination of specific antibodies in immunized mice].
Xu YG; Cui LC; Ge JW; Zhao LL; Li YJ
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):667-72. PubMed ID: 17944369
[TBL] [Abstract][Full Text] [Related]
12. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.
Pan Q; He K; Huang K
Vaccine; 2008 Apr; 26(17):2119-26. PubMed ID: 18378364
[TBL] [Abstract][Full Text] [Related]
13. Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose.
Ju H; Wei N; Wang Q; Wang C; Jing Z; Guo L; Liu D; Gao M; Ma B; Wang J
Biochem Biophys Res Commun; 2011 May; 409(1):131-6. PubMed ID: 21554858
[TBL] [Abstract][Full Text] [Related]
14. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
[TBL] [Abstract][Full Text] [Related]
15. Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.
Pan Q; He K; Wang Y; Wang X; Ouyang W
Virus Genes; 2013 Jun; 46(3):465-72. PubMed ID: 23430711
[TBL] [Abstract][Full Text] [Related]
16. A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure.
Antonis AF; Bruschke CJ; Rueda P; Maranga L; Casal JI; Vela C; Hilgers LA; Belt PB; Weerdmeester K; Carrondo MJ; Langeveld JP
Vaccine; 2006 Jun; 24(26):5481-90. PubMed ID: 16730104
[TBL] [Abstract][Full Text] [Related]
17. Production and immunogenicity of VP2 protein of porcine parvovirus expressed in Pichia pastoris.
Guo C; Zhong Z; Huang Y
Arch Virol; 2014 May; 159(5):963-70. PubMed ID: 24221249
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
[TBL] [Abstract][Full Text] [Related]
19. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant Vp2 protein of infectious bursal disease virus AH1 strain expressed in insect cells: a vaccine candidate].
Ouyang W; Wang Y; Zhou Y; Zhang H; Tang Y
Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):595-603. PubMed ID: 20684302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]